The owner of Calvin Klein and Tommy Hilfger has been placed on China’s unreliable entities list, which could force it to cease operations in the […]

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face competition from cheaper generics.